Teva Reaffirms Growth Strategy, Eyes $5 Billion Innovative Franchise By 2030

benzinga.com/general/biotech/25/05/45678673/teva-reaffirms-growth-strategy-eyes-5-billion-innovative-franchise-by-2030

Israeli multinational pharmaceutical company Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) hosted 2025 Innovation & Strategy Day on Thursday to launch the acceleration phase of its “Pivot to Growth” strategy and to discuss portfolio priorities.
The company outlined its plan to evolve…

This story appeared on benzinga.com, 2025-05-29 18:14:39.
The Entire Business World on a Single Page. Free to Use →